Education
About Us
Working with TipRanks
Follow Us
Calcimedica, Inc. (CALC)
NASDAQ:CALC
Total Valuation
CalciMedica has a market cap or net worth of $89.77M. The enterprise value is $41.19M.
Market Cap$89.77M
Enterprise Value$41.19M
Share Statistics
CalciMedica has 14,409,431 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,409,431
Owned by Insiders39.32%
Owned by Institutions19.48%
Financial Efficiency
CalciMedica’s return on equity (ROE) is -0.95 and return on invested capital (ROIC) is -150.24%.
Return on Equity (ROE)-0.95
Return on Assets (ROA)-0.69
Return on Invested Capital (ROIC)-150.24%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee0.00
Profits Per Employee-978.57K
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CalciMedica is ―. CalciMedica’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio2.76
Price to Fair Value2.76
Price to FCF-1.88
Price to Operating Cash Flow-3.02K
PEG Ratio0.03
Income Statement
In the last 12 months, CalciMedica had revenue of 0.00 and earned -13.70M in profits. Earnings per share was -1.22.
Revenue0.00
Gross Profit0.00
Operating Income-24.20M
Pretax Income-13.70M
Net Income-13.70M
EBITDA-24.15M
Earnings Per Share (EPS)-1.22
Cash Flow
In the last 12 months, operating cash flow was -21.30M and capital expenditures -24.00K, giving a free cash flow of -21.32M billion.
Operating Cash Flow-21.30M
Free Cash Flow-21.32M
Free Cash Flow per Share-1.48
Dividends & Yields
CalciMedica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.24
52-Week Price Change89.36%
50-Day Moving Average3.92
200-Day Moving Average2.74
Relative Strength Index (RSI)73.89
Average Volume (3m)71.94K
Important Dates
CalciMedica upcoming earnings date is Mar 26, 2026, After Close (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
CalciMedica as a current ratio of 5.34, with Debt / Equity ratio of 0.00%
Current Ratio5.34
Quick Ratio5.34
Debt to Market Cap0.00
Net Debt to EBITDA0.58
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CalciMedica has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CalciMedica EV to EBITDA ratio is -2.34, with an EV/FCF ratio of -1.51.
EV to Sales0.00
EV to EBITDA-2.34
EV to Free Cash Flow-1.51
EV to Operating Cash Flow-1.51
Balance Sheet
CalciMedica has $14.08M in cash and marketable securities with $8.90M in debt, giving a net cash position of $5.18M billion.
Cash & Marketable Securities$14.08M
Total Debt$8.90M
Net Cash$5.18M
Net Cash Per Share$0.36
Tangible Book Value Per Share$1.28
Margins
Gross margin is 1.67%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin1.67%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for CalciMedica is $20.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$20.00
Price Target Upside377.33% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-2.46%